The FDA has launched Drug Safety Newsletter, a quarterly digest of post-marketing drug safety reviews, important emerging drug safety issues and recently approved drugs for healthcare professionals. The newsletter is part of FDA’s response to the Institute of Medicine’s 2006 report, The Future of Drug Safety—Promoting and Protecting the Public.
From the November 01, 2007 Issue of MM+M - Medical Marketing and Media
